Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
However, Vertex Pharmaceuticals (NASDAQ: VRTX) , a drugmaker with a monopoly in the cystic fibrosis (CF) market, hasn't done that -- quite the contrary. Since it launched its first CF product some 12 years ago, the biotech hasn't stopped innovating and improving its lineup. And it still isn't done. Vertex Pharmaceuticals is making steady progress toward earning approval for a new CF medicine. Stellar clinical trial results CF is a rare disease that disrupts the proper functioning of internal organs, including the lungs and the pancreas. Though standards of care existed before Vertex, the biotech developed the only medicines in the world that target the underlying genetic causes of the illness. Its success in the past 12 years directly results from this work, though many have tried to emulate it. So far, no other drugmaker has successfully challenged Vertex Pharmaceuticals in this area. And while others still struggle to produce positive clinical trial results in CF, Vertex Phar
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Got $500? 3 Pharma Stocks to Buy and Hold Forever [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow [Yahoo! Finance]Yahoo! Finance
- 2 Biotech Stocks to Buy in May [Yahoo! Finance]Yahoo! Finance
- Vertex to Participate in Upcoming June Investor Conferences [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/28/24 - Form 144
- 5/24/24 - Form 4
- 5/24/24 - Form 144
- VRTX's page on the SEC website